XIPERE
Total Payments
$1.1M
Transactions
4,431
Doctors
1,574
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $175,710 | 1,083 | 573 |
| 2023 | $227,362 | 1,369 | 747 |
| 2022 | $559,433 | 1,827 | 872 |
| 2021 | $78,460 | 122 | 73 |
| 2020 | $37,217 | 30 | 16 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $624,256 | 298 | 57.9% |
| Compensation for serving as faculty or as a speaker for a medical education program | $224,086 | 237 | 20.8% |
| Food and Beverage | $134,424 | 3,751 | 12.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $63,518 | 15 | 5.9% |
| Travel and Lodging | $28,105 | 106 | 2.6% |
| Space rental or facility fees (teaching hospital only) | $3,500 | 1 | 0.3% |
| Education | $291.87 | 23 | 0.0% |
Top Doctors Receiving Payments for XIPERE — Page 4
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Ophthalmology | Stanford, CA | $1,035 | 1 |
| , MD | Retina Specialist | Palo Alto, CA | $1,035 | 1 |
| , MD | Ophthalmology | Orange, CA | $1,015 | 2 |
| , MD | Ophthalmology | Houston, TX | $943.57 | 12 |
| , M.D | Ophthalmology | Los Angeles, CA | $837.41 | 11 |
| , MD | Uveitis and Ocular Inflammatory Disease | Los Angeles, CA | $799.21 | 7 |
| , M.D | Ophthalmology | Beachwood, OH | $748.43 | 9 |
| , MD | Ophthalmology | Springfield, IL | $728.99 | 7 |
| , MD | Ophthalmology | Madison, WI | $597.18 | 7 |
| , MEDICAL STUDENT | Ophthalmology | Cleveland, OH | $571.40 | 5 |
| , MD | Ophthalmology | Valhalla, NY | $568.08 | 5 |
| , MD | Retina Specialist | New York, NY | $534.37 | 6 |
| , MD | Student in an Organized Health Care Education/Training Program | Durham, NC | $526.41 | 23 |
| , M.D | Ophthalmology | East Setauket, NY | $490.86 | 5 |
| , MD | Retina Specialist | Royal Oak, MI | $486.10 | 8 |
| , MD | Internal Medicine | Dallas, TX | $483.26 | 22 |
| , MD | Retina Specialist | Phoenix, AZ | $482.54 | 19 |
| , M.D., PH.D | Ophthalmology | Portland, OR | $468.31 | 12 |
| , MD | Ophthalmology | San Francisco, CA | $462.47 | 7 |
| , M.D | Ophthalmology | Cleveland, OH | $438.80 | 18 |
| , MD | Retina Specialist | Atlanta, GA | $398.50 | 7 |
| , MD | Ophthalmology | Tampa, FL | $394.83 | 6 |
| , MD | Ophthalmology | Wilson, NC | $377.01 | 6 |
| , MD | Ophthalmology | Atlanta, GA | $373.05 | 6 |
| , MD | Retina Specialist | Tampa, FL | $364.75 | 7 |
Ad
Manufacturing Companies
Product Information
- Type Drug
- Total Payments $1.1M
- Total Doctors 1,574
- Transactions 4,431
About XIPERE
XIPERE is a drug associated with $1.1M in payments to 1,574 healthcare providers, recorded across 4,431 transactions in the CMS Open Payments database. The primary manufacturer is Bausch & Lomb Americas Inc..
Payment data is available from 2020 to 2024. In 2024, $175,710 was paid across 1,083 transactions to 573 doctors.
The most common payment nature for XIPERE is "Consulting Fee" ($624,256, 57.9% of total).